Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Non-cash Items (2019 - 2025)

Historic Non-cash Items for SRx Health Solutions (SRXH) over the last 5 years, with Q1 2025 value amounting to $45473.0.

  • SRx Health Solutions' Non-cash Items rose 35.97% to $45473.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $45473.0, marking a year-over-year increase of 35.97%. This contributed to the annual value of $46.0 for FY2023, which is 612.24% down from last year.
  • SRx Health Solutions' Non-cash Items amounted to $45473.0 in Q1 2025, which was up 35.97% from $200000.0 recorded in Q3 2024.
  • In the past 5 years, SRx Health Solutions' Non-cash Items ranged from a high of $200000.0 in Q2 2024 and a low of $46.0 during Q4 2023
  • Moreover, its 4-year median value for Non-cash Items was $47885.0 (2023), whereas its average is $73999.5.
  • Per our database at Business Quant, SRx Health Solutions' Non-cash Items plummeted by 612.24% in 2023 and then surged by 29763.8% in 2024.
  • Over the past 4 years, SRx Health Solutions' Non-cash Items (Quarter) stood at $49.0 in 2022, then decreased by 6.12% to $46.0 in 2023, then soared by 434682.61% to $200000.0 in 2024, then plummeted by 77.26% to $45473.0 in 2025.
  • Its Non-cash Items was $45473.0 in Q1 2025, compared to $200000.0 in Q3 2024 and $200000.0 in Q2 2024.